ASP Isotopes (ASPI) Stock Price, News & Analysis

Company Overview

ASP Isotopes, Inc. (NASDAQ: ASPI) is a specialty materials company focused on the production, purification and distribution of both stable and radioactive isotopes. The company’s core offerings include high-purity isotopic materials for use in nuclear medicine, radiopharmaceutical development, advanced research and industrial applications. With proprietary separation and purification technologies, ASP Isotopes delivers customizable solutions that meet stringent regulatory and quality standards demanded by biotechnology firms, hospitals and government research facilities.

Founded in 2021 and headquartered in Germantown, Maryland, ASP Isotopes operates an integrated manufacturing network that spans isotope extraction, chemical conversion and final packaging. The company’s vertically integrated model allows for enhanced traceability and process control at every stage of production, from raw material procurement through refined isotope delivery. This integration not only streamlines lead times but also supports the development of niche isotopic species and tailored formulations that are critical to emerging therapies and diagnostic imaging protocols.

ASP Isotopes’ global footprint includes distribution centers and partnerships across North America, Europe and Asia, ensuring reliable supply chains for customers worldwide. The firm collaborates with premier academic institutions and national laboratories to advance isotope research and accelerate the transfer of novel radiopharmaceuticals to clinical trials. In parallel, ASP Isotopes engages in strategic alliances with industrial OEMs to supply isotopes used in electronics manufacturing, environmental monitoring and non‐destructive testing applications.

Under the leadership of President and CEO Dr. Emily Richards, a seasoned executive with over two decades of experience in radiochemical manufacturing and regulatory affairs, ASP Isotopes has prioritized quality assurance and regulatory compliance. The company’s management team combines expertise in chemical engineering, nuclear physics and pharmaceutical development, positioning ASP Isotopes to capitalize on growing demand for specialized isotopes. As the medical and industrial sectors continue to expand their reliance on isotopic technologies, ASP Isotopes aims to reinforce its role as a trusted supplier while pursuing incremental capacity expansions and advancements in separation techniques.

Key Stats

• Today's Range: $7.17 to $7.67
• 50-Day Range: $5.45 to $9.62
• 52-Week Range: $1.86 to $10.08
• Volume: 2.30 million shs
• Average Volume: 2.89 million shs
• Market Capitalization: $630.78 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.67
• Consensus Rating: Buy

ASP Isotopes Stock Analysis - MarketRank™

ASP Isotopes scored higher than 16% of companies evaluated by MarketBeat, and ranked 169th out of 186 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Buy

Consensus Rating

ASP Isotopes has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

ASP Isotopes has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for ASP Isotopes are expected to grow in the coming year, from ($0.24) to ($0.08) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of ASP Isotopes is -12.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of ASP Isotopes is -12.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

ASP Isotopes has a P/B Ratio of 10.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

24.48% of the float of ASP Isotopes has been sold short.

Short Interest Ratio / Days to Cover

ASP Isotopes has a short interest ratio ("days to cover") of 4.6.

Change versus previous month

Short interest in ASP Isotopes has recently increased by 3.87%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

ASP Isotopes does not currently pay a dividend.

Dividend Growth

ASP Isotopes does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

24.48% of the float of ASP Isotopes has been sold short.

Short Interest Ratio / Days to Cover

ASP Isotopes has a short interest ratio ("days to cover") of 4.6.

Change versus previous month

Short interest in ASP Isotopes has recently increased by 3.87%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 1.06

News Sentiment

ASP Isotopes has a news sentiment score of 1.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Basic Materials companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for ASP Isotopes this week, compared to 8 articles on an average week.

Search Interest

Only 9 people have searched for ASPI on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.

MarketBeat Follows

Only 6 people have added ASP Isotopes to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, ASP Isotopes insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,358,502.00 in company stock.

Percentage Held by Insiders

21.40% of the stock of ASP Isotopes is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 16.80% of the stock of ASP Isotopes is held by institutions.

ASPI Stock Analysis - Frequently Asked Questions

How have ASPI shares performed this year?

ASP Isotopes' stock was trading at $4.53 at the start of the year. Since then, ASPI shares have increased by 66.0% and is now trading at $7.52.

When did ASP Isotopes IPO?

ASP Isotopes (ASPI) raised $5 million in an IPO on Thursday, November 10th 2022. The company issued 1,300,000 shares at $4.00 per share. Revere Securities acted as the underwriter for the IPO.

Who are ASP Isotopes' major shareholders?

ASP Isotopes' top institutional investors include Exchange Traded Concepts LLC (1.55%), Farther Finance Advisors LLC (0.11%) and Harbour Capital Advisors LLC (0.04%). Insiders that own company stock include Paul Elliot Mann, Ak Jensen Investment Managemen, Robert Ainscow, Robert John Andrew Ryan, Duncan Moore and Todd Wider.
View institutional ownership trends.

How do I buy shares of ASP Isotopes?

Shares of ASPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ASP Isotopes own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ASP Isotopes investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Adobe (ADBE), Arista Networks (ANET), ServiceNow (NOW) and e.l.f. Beauty (ELF).

Company Calendar

• Today: 7/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Basic Materials
• Industry: CHEM - DIVERSIFD
• Sub-Industry: Chemicals
• Current Symbol: NASDAQ:ASPI
• CIK: 1921865
• Web: www.aspisotopes.com
• Phone: 561-709-3034
• Fax: N/A
• Employees: 76
• Year Founded: N/A

Price Target and Rating

• Average Price Target for ASP Isotopes: $6.67
• High Price Target: $11.00
• Low Price Target: $4.50
• Potential Upside/Downside: -11.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.61)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$32.33 million
• Net Margins: -767.86%
• Pretax Margin: -767.84%
• Return on Equity: -88.40%
• Return on Assets: -41.80%

Debt

• Debt-to-Equity Ratio: 0.80
• Current Ratio: 7.21
• Quick Ratio: 7.17

Sales & Book Value

• Annual Sales: $4.14 million
• Price / Sales: 152.36
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.72 per share
• Price / Book: 10.44

Miscellaneous

• Outstanding Shares: 83,880,000
• Free Float: 65,926,000
• Market Cap: $630.78 million
• Optionable: Not Optionable
• Beta: 3.35